Search Results

You are looking at 31 - 40 of 134 items for :

  • Refine by Access: All x
Clear All
Full access

Gordon Taylor Moffat, Lilian Hanna, Wilma Hopman, Andrea S. Fung, and Pierre-Olivier Gaudreau

Background : The COVID-19 pandemic led to Cancer Care Ontario’s approval of extended dosing (ED) of pembrolizumab in the management of metastatic non-small cell lung cancer (mNSCLC) as a means of reducing the risk of exposure through less visits

Full access

Derek Falk and Bradley J. Zebrack

The COVID-19 pandemic has amplified the need for healthcare systems to integrate digital tools, including patient portals, telehealth, and electronic health records, to optimize whole-person cancer care. Pandemic protocols have limited and, in

Full access

Neil Iyengar, Clay Williams, Michael Rogan, Laurie Campbell, Shirley Mertz, Jeremy Block, Maria Ebling, Connie Chen, Justin Doan, Samantha K. Kurosky, and Timothy Pluard

Background : Significant changes were made in healthcare treatment (tx), safety standards, and protocols during the COVID-19 pandemic. mBC pts are particularly vulnerable to such changes, making it critical to understand their perspectives

Full access

Anil K. Rengan and Crystal S. Denlinger

radiographic response at her first disease evaluation 2 months into treatment ( Figure 2 ). Figure 2. CT images at (A) treatment initiation, (B) CA 19-9 nadir, (C) treatment hold for COVID-19, and (D) disease progression. The patient’s course

Full access

Lynn A. McCain, Kara J. Milliron, Amanda M. Cook, Robert Paquette, Jasmine B. Parvaz, Susan D. Ernst, Anne L. Kittendorf, Diane M. Harper, Philip Zazove, Jim Arthurs, Jerry A. Tippie, Bailey Hulswit, Lee F. Schroeder, David F. Keren, and Sofia D. Merajver

-point scale). (C) Understandability (scores of ≥3 on a 5-point scale). Note: 2019 Q4 and 2020 Q1 are omitted due to restructuring of clinics during the COVID-19 pandemic. Abbreviations: GC, genetics clinic; PCC, primary care clinic; Q, quarter

Full access

Presenters: Lucy R. Langer, Amye J. Tevaarwerk, and Robin Zon

Moderator : Travis Osterman

The Clinician Perspective Telemedicine refers to a remote clinical service between a patient and healthcare professional. Although it may seem that telemedicine was not widely used until the onset of the COVID-19 pandemic, the concept is

Full access

Narek Shaverdian, Erin F. Gillespie, Elaine Cha, Soo Young Kim, Stephanie Benvengo, Fumiko Chino, Jung Julie Kang, Yuelin Li, Thomas M. Atkinson, Nancy Lee, Charles M. Washington, Oren Cahlon, and Daniel R. Gomez

Background The coronavirus disease 2019 (COVID-19) pandemic has transformed cancer care in the United States with the rapid expansion of telemedicine into routine patient evaluation and management. 1 Patients with cancer are vulnerable to